Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 6/20 | 1.00 |
| ▸ | CCR1 | P32246 | 1/20 | 0.56 |
| ▸ | CCR8 | P51685 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.53 |
| ▸ | KARS1 | Q15046 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.51 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.51 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.51 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.50 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.50 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.50 |
| ▸ | ABL1 | P00519 | 1/20 | 0.49 |
| ▸ | BCR | P11274 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | GRM5 | P41594 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19009235 | 0.90 | CYP2A6 (0.81) | CYP2A6CCR1CCR8CYP3A4KARS1 | |
| SCHEMBL3194702 | 0.86 | CYP2A6 (0.74) | CYP2A6CYP3A4KARS1ALDH1A1CYP1A2 | |
| SCHEMBL15293831 | 0.82 | CYP2A6 (0.68) | CYP2A6CYP3A4KARS1ALDH1A1CYP1A2 | |
| SCHEMBL2237033 | 0.82 | CYP2A6 (0.68) | CYP2A6CCR1CCR8CYP3A4KARS1 | |
| SCHEMBL12339136 | 0.81 | CYP2A6 (0.69) | CYP2A6CYP3A4KARS1ALDH1A1CYP1A2 | |
| SCHEMBL12925671 | 0.81 | CYP2A6 (0.69) | CYP2A6CYP3A4KARS1ALDH1A1CYP1A2 | |
| SCHEMBL13097166 | 0.81 | CYP2A6 (0.68) | CYP2A6CYP3A4ALDH1A1CYP1A2HSP90AA1 | |
| SCHEMBL10181969 | 0.81 | CYP2A6 (0.67) | CYP2A6CCR1CCR8CYP3A4ALDH1A1 | |
| SCHEMBL3421988 | 0.80 | CYP2A6 (0.67) | CYP2A6CCR1CCR8 | |
| SCHEMBL4581601 | 0.80 | CYP2A6 (0.67) | CYP2A6CCR1CCR8KMT2AGRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11877506-B2 | Polycyclic aromatic compound | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2024-01-16 | — | — | US | disclosed |
| US-11818932-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-14 | — | — | US | disclosed |
| US-11800785-B2 | Material for organic device and organic electroluminescent device using the same | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2023-10-24 | — | — | US | disclosed |
| US-11800785-B2 | Material for organic device and organic electroluminescent device using the same | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2023-10-24 | — | — | US | disclosed |
| US-20230276708-A1 | Polycyclic aromatic compound | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2023-08-31 | — | — | US | disclosed |
| US-11723263-B2 | Organic electroluminescent element | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2023-08-08 | — | — | US | disclosed |
| US-11723263-B2 | Organic electroluminescent element | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2023-08-08 | — | — | US | disclosed |
| US-11706973-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-18 | — | — | US | disclosed |
| US-11696496-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-04 | — | — | US | disclosed |
| US-11678498-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-13 | — | — | US | disclosed |
| US-20080188527-A1 | Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer | HUMAN BIOMOLECULAR RESEARCH INSTITUTE | 2008-08-07 | — | — | US | disclosed |
| EP-1930329-A1 | 1,3,5-TRIAZINE DERIVATIVE, METHOD FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING SAME AS COMPONENT | Tosoh Corporation (JP) | 2008-06-11 | — | — | EP | disclosed |
| US-7307171-B2 | Materials and methods for inhibiting fouling of surfaces exposed to aquatic environments | UNIVERSITY OF FLORIDA (US) | 2007-12-11 | — | — | US | disclosed |
| WO-2007098961-A1 | 4, 5, 6,7-TETRAHYDROBENZO[B]THIOPHENE DERIVATIVES AND THEIR USE AS SIGMA RECEPTOR LIGANDS | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2007-09-07 | — | — | WO | disclosed |
| EP-1829869-A1 | 4,5,6,7-Tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2007-09-05 | — | — | EP | disclosed |
| US-7087106-B2 | Materials and methods for inhibiting fouling of surfaces exposed to aquatic environments | UNIVERSITY OF FLORIDA (US) | 2006-08-08 | — | — | US | disclosed |
| US-20050159454-A1 | Materials and methods for inhibiting fouling of surfaces exposed to aquatic environments | KEM WILLIAM R (US) | 2005-07-21 | — | — | US | disclosed |
| WO-2005066162-A1 | SYNTHETIC COMPOUNDS AND DERIVATIVES AS MODULATORS OF SMOKING OR NICOTINE INGESTION AND LUNG CANCER | HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) | 2005-07-21 | — | — | WO | disclosed |
| WO-2005023942-A2 | MATERIALS AND METHODS FOR INHIBITING FOULING OF SURFACES EXPOSED TO AQUATIC ENVIRONMENTS | UNIVERSITY OF FLORIDA (US) | 2005-03-17 | — | — | WO | disclosed |
| US-20040235901-A1 | Materials and methods for inhibiting fouling of surfaces exposed to aquatic environments | DUKE UNIVERSITY | 2004-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11877506-B2 | Polycyclic aromatic compound | F11, C1R, RNF31 | CYP2A6 1085/4885CCR1 59/4885CCR8 689/4885 |
| US-20230276708-A1 | Polycyclic aromatic compound | ACVR1B, XDH, AHR | CYP2A6 303/4885CCR1 300/4885CCR8 943/4885 |
| US-20080188527-A1 | Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer | CYP2A13, CYP2A6, CYP2B6 | CYP2A6 2/4885CCR1 2727/4885CCR8 3198/4885 |
| US-11706973-B2 | Condensed cyclic compound and organic light-emitting device including the same | C1S, CCNT1, C9 | CYP2A6 213/4885CCR1 72/4885CCR8 874/4885 |
| US-11723263-B2 | Organic electroluminescent element | NR4A3, AFF4, NR4A1 | CYP2A6 2062/4885CCR1 1726/4885CCR8 1873/4885 |
| US-11800785-B2 | Material for organic device and organic electroluminescent device using the same | RER1, LEF1, CHRM1 | CYP2A6 3304/4885CCR1 255/4885CCR8 1880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.